Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
Guest: Dr. Jon Zippin What happens when two longtime friends, dermatologists, and self-proclaimed science nerds get together to talk about pigment? Well, this one time, at band cAMP…. Anyway, in…
Comparing Targeted Systemic Therapies and Incident Psoriatic Arthritis Risk in Psoriasis Patients Have you read this article from the JDD? For dermatology providers managing complex psoriasis cases, predicting and mitigating…
Optimizing Atopic Dermatitis Outcomes: Nordic Expert Panel Insights on Emollient Selection and Treatment Concordance Check out this groundbreaking publication featured in the Journal of Drugs in Dermatology. Managing chronic atopic…
Bridging the Evidence Gap in Skin of Color Hyperpigmentation This is a must-read article from the Journal of Drugs in Dermatology (JDD) that every practicing clinician should have on their…
Pigmentary disorders, including cutaneous hyperpigmentation, are among the most common dermatologic diagnoses in individuals with SOC, particularly individuals with African, Asian, or Hispanic heritage. The principal hyperpigmentation conditions include melasma, post-inflammatory…
Protecting the Pediatric Skin Barrier: Expert Consensus on Environmental Triggers and Early Intervention This is a must-read article from JDD for clinicians managing pediatric skin health. Atopic dermatitis frequently begins in…